Vlad working on Natural Killer (NK) car-T cells targeting Covid16 Sep 2020 00:11
First lets go back to the Webinar Vlad did (which feels like ages ago). Only 100 people (inc me) got to watch it.
The powerpoint slides shown were part of a much bigger presentation (that we didn't get to see). But was obviously created for some other purpose!
However, eagle eyed, we spotted something on one of the other slides not used (as there were tiny versions in the side bar). This referred to.NK car-t cells etc.
During the presentation Vlad also said re Covid: "we will be able to seriously contribute to this disease".
Now, today we have his tweet regarding NT natural killer car-t celks that can be reprogrammed: "there are new T and NK #celltherapies that are known and there is a new- new generation that is coming but are not widely discussed yet......."
With CDX done and just waiting on Eli Lilly, and car-T partnered off to Penn. Vlad and his team won't be sat on their arse. They could have full focus now on Covid. Hemo could have developed the 'new-new' to attack Covid. That would be a serious contribution. They must be working on or with NK car-t otherwise why have it on a slide that we're not to see? Because it is hush hush imo.
There has not been a Covid update. This could be why. The team are beavering away on NK to treat Covid? They must be making progress or we'd have had an RNS saying it was a dead duck and they were ending it.
So the flip side of that is that they ARE making progress and if a NK car-t covid RNS update lands then given the inbound 2nd wave, the sp would rocket.
Just my thoughts. Make of these what you will.